[Retracted] Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression

Table 2

Comparison of clinical efficacy (n (%)).

	Conventional group (n = 40)	Experimental group (n = 40)	x^2	value
CR	8	13
PR	11	20
SD	7	3
PD	14	4
RR	19 (48%)	33 (83%)	10.769	0.001
DCR	26 (65%)	36 (90%)	7.168	0.007